Atlas Trials

Phase 3 Study of YM060 in Patients With Diarrhea-predominant Irritable Bowel Syndrome (d-IBS)

Clinical trial NCT00189696 · COMPLETED

Trial details

NCT number
NCT00189696
Sponsor
Astellas Pharma Inc
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Irritable Bowel Syndrome

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.